Several therapeutic agents have therefore been targeted against the UPR or against GRP78/BiP to curb tumor cell growth but truly selective inhibitors are yet to be identified
nuclear lumen and nucleoplasmic reticulum, the latter two have been suggested to increase/enhance signals...